Biofil Chemicals P/E Ratio
Current P/E Ratio
21.04
Moderate Valuation
High - Growth expectations or overvalued
Biofil Chemicals (BIOFILCHEM) P/E ratio is 21.04 (Moderate), EPS (TTM) ₹1.71, current price ₹33.71 on NSE — High - Growth expectations or overvalued. Read BIOFILCHEM dividend yield for the complete payout history and dividend yield track record.
Current Valuation Metrics
P/E Ratio
21.04
Current Price
₹33.71
EPS (TTM)
₹1.71
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
54.97
Sector Median
31.4
Sector Rank
#11 of 194
Sector Percentile
5.7%
BIOFILCHEM P/E Ratio — Valuation Signal & Historical Context
Biofil Chemicals P/E 21.04 — signal: Overvalued. See Biofil Chemicals P/B valuation to compare market price against book value per share.
- Trading at discount to sector average PE of 54.97
BIOFILCHEM vs Healthcare Peers — P/E Ratio Comparison
Biofil Chemicals P/E 21.04 vs Healthcare average 54.97, median 31.4 — range 2.86–950.0.
Sector Average
54.97
Sector Median
31.4
Lowest P/E
2.86
Highest P/E
950.0
Companies
194
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.65 | ₹29 | Low |
| Phaarmasia | PHRMASI | 3.89 | ₹69 | Low |
| JFL Life Sciences | JFLLIFE | 4.64 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.69 | ₹7,502 | Low |
| Shelter Pharma | SHELTER | 5.32 | ₹50 | Low |
| Mono Pharmacare | MONOPHARMA | 6.02 | ₹19 | Low |
| Royal Sense | ROYAL | 7.4 | ₹51 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹79 | Low |
| Amwill Health Care | AMWILL | 7.71 | ₹88 | Low |